Detection of bacteriuria and pyuria by URISCREEN a rapid enzymatic screening test. 1992

M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
Department of Pathology, University of California Irvine Medical Center, Orange 92668.

A multicenter study was performed to evaluate the ability of the URISCREEN (Analytab Products, Plainview, N.Y.), a 2-min catalase tube test, to detect bacteriuria and pyuria. This test was compared with the Chemstrip LN (BioDynamics, Division of Boehringer Mannheim Diagnostics, Indianapolis, Ind.), a 2-min enzyme dipstick test; a semiquantitative plate culture method was used as the reference test for bacteriuria, and the Gram stain or a quantitative chamber count method was used as the reference test for pyuria. Each test was evaluated for its ability to detect probable pathogens at greater than or equal to 10(2) CFU/ml and/or greater than or equal to 1 leukocyte per oil immersion field, as determined by the Gram stain method, or greater than 10 leukocytes per microliter, as determined by the quantitative count method. A total of 1,500 urine specimens were included in this evaluation. There were 298 specimens with greater than or equal 10(2) CFU/ml and 451 specimens with pyuria. Of the 298 specimens with probable pathogens isolated at various colony counts, 219 specimens had colony counts of greater than or equal to 10(5) CFU/ml, 51 specimens had between 10(4) and 10(5) CFU/ml, and 28 specimens had between 10(2) and less than 10(4) CFU/ml. Both the URISCREEN and the Chemstrip LN detected 93% (204 of 219) of the specimens with probable pathogens at greater than or equal to 10(5) CFU/ml. For the specimens with probable pathogens at greater than or equal to 10(2) CFU/ml, the sensitivities of the URISCREEN and the Chemstrip LN were 86% (256 of 298) and 81% (241 of 298), respectively. Of the 451 specimens with pyuria, the URISCREEN detected 88% (398 of 451) and Chemstrip LN detected 78% (350 if 451). There were 204 specimens with both greater than or equal to 10(2) CFU/ml and pyuria; the sensitivities of both methods were 95% (193 of 204) for these specimens. Overall, there were 545 specimens with probable pathogens at greater than or equal to 10(2) CFU/ml and/or pyuria. The URISCREEN detected 85% (461 of 545), and the Chemstrip LN detected 73% (398 of 545). A majority (76%) of the false-negative results obtained with either method were for specimens without leukocytes in the urine. There were 955 specimens with no probable pathogens or leukocytes. Of these, 28% (270 of 955) were found positive by the URISCREEN and 13% (122 of 955) were found positive by the Chemstrip LN. A majority of the false-positive results were probably due, in part, to the detection of enzymes present in both bacterial and somatic cells by each of the test systems. Overall, the URISCREEN is rapid, manual, easy-to-perform enzymatic test that yields findings similar to those yielded by the Chemstrip LN for specimens with both greater than or equal to 10(2) CFU/ml and pyuria or for specimens with greater than or equal to 10(5) CFU/ml and with or without pyuria. However, when the data were analyzed for either probable pathogens at less 10(5) CFU/ml or pyuria, the sensitivity of the URISCREEN was higher (P less than 0.05).

UI MeSH Term Description Entries
D011776 Pyuria The presence of white blood cells (LEUKOCYTES) in the urine. It is often associated with bacterial infections of the urinary tract. Pyuria without BACTERIURIA can be caused by TUBERCULOSIS, stones, or cancer. Pyurias
D003951 Diagnostic Errors Incorrect or incomplete diagnoses following clinical or technical diagnostic procedures. Diagnostic Blind Spots,Errors, Diagnostic,Misdiagnosis,Blind Spot, Diagnostic,Blind Spots, Diagnostic,Diagnostic Blind Spot,Diagnostic Error,Error, Diagnostic,Misdiagnoses
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic
D001437 Bacteriuria The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection. Bacteriurias
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
March 1996, Obstetrics and gynecology,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
April 2000, Obstetrics and gynecology,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
February 1997, The Journal of urology,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
January 2005, Journal of the Society for Gynecologic Investigation,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
January 2002, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
April 1985, Journal of clinical microbiology,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
June 1967, Archives of disease in childhood,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
November 1966, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
December 1994, JPMA. The Journal of the Pakistan Medical Association,
M T Pezzlo, and D Amsterdam, and J P Anhalt, and T Lawrence, and N J Stratton, and E A Vetter, and E M Peterson, and L M de la Maza
February 1969, British journal of urology,
Copied contents to your clipboard!